Author

T. Koyama

h-index 0 View on Semantic Scholar

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

First-week expansion of activated peripheral B-cell subsets is associated with grade 3 or higher immune-related adverse events after nivolumab plus ipilimumab

First-week expansion of activated peripheral B-cell subsets after nivolumab plus ipilimumab was associated with subsequent severe irAEs, which support future studies of early B-cell monitoring within integrated multimarker assessments of irAE risk.

H. Takakura, Y. Funakoshi, T. Koyama et al. · medRxiv · 0 citations